<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://prevencia.ro/stiri/cancer-pulmonar-ivonescimab-refuz-fda</loc>
    <lastmod>2026-11-16T12:39:13.762Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Clinica Prevencia</news:name>
        <news:language>ro</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T12:39:13.762Z</news:publication_date>
      <news:title>Cancer pulmonar cu mutație EGFR: FDA refuză ivonescimab, fără dovada clară că prelungește viața</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://prevencia.ro/stiri/ghid-diabet-cnas-preventie-tratament</loc>
    <lastmod>2026-11-16T12:38:22.260Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Clinica Prevencia</news:name>
        <news:language>ro</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T12:38:22.260Z</news:publication_date>
      <news:title>Ghid pentru diabet de la CNAS: testare de la 35 de ani și analize de prevenție pentru neasigurați</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://prevencia.ro/stiri/obezitatea-adolescenti-tirzepatida-studiu</loc>
    <lastmod>2026-11-16T12:09:08.877Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Clinica Prevencia</news:name>
        <news:language>ro</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T12:09:08.877Z</news:publication_date>
      <news:title>Obezitatea la adolescenți: tirzepatida a redus IMC-ul cu 18,5% într-un studiu de 72 de săptămâni</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://prevencia.ro/stiri/lupus-activ-gazyvaro-aviz-european</loc>
    <lastmod>2026-11-15T18:36:32.024Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Clinica Prevencia</news:name>
        <news:language>ro</news:language>
      </news:publication>
      <news:publication_date>2026-11-15T18:36:32.024Z</news:publication_date>
      <news:title>Lupusul activ în ciuda tratamentului: EMA recomandă adăugarea medicamentului Gazyvaro</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://prevencia.ro/stiri/tratamentul-obezitatii-cagrisema-doze-mici</loc>
    <lastmod>2026-11-15T18:33:18.860Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Clinica Prevencia</news:name>
        <news:language>ro</news:language>
      </news:publication>
      <news:publication_date>2026-11-15T13:20:27.967Z</news:publication_date>
      <news:title>Tratamentul obezității: Novo anunță rezultate pentru două doze mai mici de CagriSema</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://prevencia.ro/stiri/adhd-copii-sprijin-clasa-studiu</loc>
    <lastmod>2026-11-15T10:19:45.037Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>Clinica Prevencia</news:name>
        <news:language>ro</news:language>
      </news:publication>
      <news:publication_date>2026-11-15T10:19:45.037Z</news:publication_date>
      <news:title>ADHD la copii: pauzele și timpul suplimentar nu au adus beneficii clare într-un studiu</news:title>
    </news:news>
  </url>
</urlset>
